Population genetic analysis of the association between the BRCA1 and P53 gene polymorphisms and the risk of sporadic breast cancer

Genetika

Volumn 41, Issue 8, 2005, Pages 1115-1124

  Tarasov, V A ^a   Aslanyan, M M ^b   Tsyrendorzhiyeva, E S ^a   Garkavtseva, R F ^c   Lyubchenko, L N ^c   Altukhov, Yu P ^a   Mel'nik, V A ^a  

^a VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; DNA POLYMORPHISM; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ALLELE; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

ALLELES; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 27744507606     PISSN: 00166758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Castilla L.H., Couch F.J., Erdos M.R. et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer // Nature Genet. 1994. V. 8. P. 387-391.
2. Smith S.A., Easton D.F., Evans D.G.R., Ponder B.A.J. Allele losses in the region 17q12-21 in familian breast and ovarian cancer involve the wild-type chromosome // Nature Genet. 1992. V. 2. P. 128-131.
3. Kelsell D.P., Black D.M., Bishop D.T., Spurr N.K. Genetic analysis of the BRCA1 region in a large breast/ovarian family: Refinement of the minimal region containing BRCA1 // Hum. Molec. Genet. 1993. V. 2. P. 1823-1828.
4. Friedman L.S., Ostermeyer E.A., Szabo C.I. et al. // Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families // Nature Genet. 1994. V. 8. P. 399-404.
5. Miki Y., Swensen J., Shattuck-Eidens D. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 // Science. 1994. V. 266. P. 66-71.
6. Easton D.F., Steele L., Fields P. et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q 12-13 // Am. J. Hum. Genet. 1997. V. 61. P. 120-128.
7. Friedman L.S., Szabo C.I., Ostermeyer E.A. et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families // Am. J. Hum. Genet. 1995. V. 57. P. 1284-1297.
8. Struewing J.P., Hartge P., Wacholder S. et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews // New Eng. J. Med. 1997. V. 336. P. 1401-1408.
9. Szabo C.I., King M.-C. Population genetics of BRCA1 and BRCA2 // Am. J. Hum. Genet. 1997. V. 60. P. 1013-1020.
10. Gorski B., Byrski T., Huzarski T. et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer // Am. J. Hum. Genet. 2000. V. 66. P. 1963-1968.
11. Arason A., Barkardottir R.B., Egilsson V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer // Am. J. Hum. Genet. 1993. V. 52. P. 711-717.
12. Schorge J.O., Muto M.G., Welch W.R. et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations // J. Nat. Cancer Inst. 1998. V. 90. P. 841-845.
13. Couch F.J., Weber B.L. Mutations and polymorphisms in the familian early-onset breast cancer (BRCA1) gene // Hum. Mutat. 1996. V. 8. P. 8-18.
14. Welsh P.L., Owens K.N. Insights into the functions of BRCA1 and BRCA2 // TIG. 2000. V. 16. P. 69-74.
15. Brzovic P.S., Rajafopal P. Structure of a BRCA1-BARD1 heterodimeric RINF-RING complex // Nature Structural Biology. 2001. V. 8. P. 833-837.
16. Wang Y., Cortez D., Yazdi P. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures // Genes Dev. 2000. V. 14. P. 927-939.
17. Wolff M.S., Weston A. Breast cancer risk and environmental exposures // Environmental Health Perspectives. 1997. V. 105. No 4. P. 891-896.
18. Vogelstein B., Kinzler K.W. The multistep nature of cancer // Trends Genet. 1993. V. 9. P. 138-141.
19. Madigan M.P., Ziegler R.G. Proportion of breast cancer cases in the United States explained by well-established risk factors // J. Natl Cancer Inst. 1995. V. 87. P. 1681-1895.
20. Gowen L.C., Avrutskaya A.V., Latour A.M. et al. BRCA1 required for transcription-coupled repair of oxidative DNA damage // Science. 1998. V. 281. P. 1009-1012.
21. Gowen L.C., Avrutskaya A.V., Latour A.M. et al. Retractin (Letter) // Science. 2003. V. 300. P. 1657.
22. Fan S., Wang J.-A., Yuan R. et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells // Science. 1999. V. 284. P. 1354-1356.
23. Bochar D.A., Wang L., Beniya H. et al. BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer // Cell. 2000. V. 102. P. 257-265.
24. Yarden R.I., Pardo-Reoyo S., Sgagias M. et al. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage // Nature Genet. 2002. V. 30. P. 265-269.
25. Hakem R., Mak T.W. Animal models of tumor-suppressor genes // Annu. Rev. Genet. 2001. V. 35. P. 209-241.
26. Gowen L.C., Johnson B.L., Latour A.M. et al. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities // Nature Genet. 1996. V. 12. P. 191-194.
27. Shen S.X., Weaver Z., Xu X. et al. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability // Oncogene. 1998. V. 17. P. 3115-3124.
28. Xu X., Wagner K.U., Larson D. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation // Nat. Genet. 1999. V. 22. P. 37-43.
29. Armitage P., Doll R. The age distribution of cancer and multi-stage theory of carcinogenesis // Br. J. Cancer. 1954. V. 8. P. 1-12.
30. Schuyer M., Berns E.M. Is TP53 dysfunction required for BRCA1-associated carcinogenesis? // Molec. Cell. Endocrin. 1999. V. 155. P. 143-152.